Tokyo Tape
Sign in
← ReproCELL

Quarterly report · Q3

4978.TEDINET S100Q5XB
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥2.2bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥2.2bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥1.5bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income−¥207m2022-04-01 → 2022-12-31Cons.Operating income
Operating income−¥529m2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income−¥37m2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income−¥507m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥351m2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax−¥37m2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax−¥351m2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)−¥39m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥575m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥351m2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income−¥39m2022-04-01 → 2022-12-31Cons.Profit loss
Net income−¥353m2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥8.3bnat 2022-12-31Cons.Assets
Total assets¥8.1bnat 2022-03-31Cons.Assets
Total assets¥7.8bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥557mat 2022-12-31Cons.Liabilities
Total liabilities¥845mat 2022-03-31Cons.Liabilities
Net assets / equity¥7.7bnat 2022-12-31Cons.Net assets
Net assets / equity¥7.3bnat 2022-03-31Cons.Net assets
Net assets / equity¥7.3bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥2.4bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥2.6bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥-0.472022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-1.272022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-7.572021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-4.742021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-1.932021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio93.3%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio89.5%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio92.7%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment ordinary income2022-04-01 → 2022-12-31−¥440m
jpcrp040300-q3r_E27585-000Medical Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥866m
jpcrp040300-q3r_E27585-000Medical Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥866m
jpcrp040300-q3r_E27585-000Medical Businessreportable segmentsegment ordinary income2022-04-01 → 2022-12-31¥204m
jpcrp040300-q3r_E27585-000Research Support Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥1.4bn
jpcrp040300-q3r_E27585-000Research Support Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.4bn
jpcrp040300-q3r_E27585-000Research Support Businessreportable segmentsegment ordinary income2022-04-01 → 2022-12-31¥200m
—segment totalrevenue2022-04-01 → 2022-12-31¥2.2bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥2.2bn
—segment totalsegment ordinary income2022-04-01 → 2022-12-31¥404m
Reconciling Itemsreconcilingsegment ordinary income2021-04-01 → 2021-12-31−¥390m
jpcrp040300-q3r_E27585-000Medical Businessreportable segmentrevenue2021-04-01 → 2021-12-31¥514m
jpcrp040300-q3r_E27585-000Medical Businessreportable segmentrevenue external2021-04-01 → 2021-12-31¥514m
jpcrp040300-q3r_E27585-000Medical Businessreportable segmentsegment ordinary income2021-04-01 → 2021-12-31−¥50m
jpcrp040300-q3r_E27585-000Research Support Businessreportable segmentrevenue2021-04-01 → 2021-12-31¥975m
jpcrp040300-q3r_E27585-000Research Support Businessreportable segmentrevenue external2021-04-01 → 2021-12-31¥975m
jpcrp040300-q3r_E27585-000Research Support Businessreportable segmentsegment ordinary income2021-04-01 → 2021-12-31¥89m
—segment totalrevenue2021-04-01 → 2021-12-31¥1.5bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥1.5bn
—segment totalsegment ordinary income2021-04-01 → 2021-12-31¥39m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 355
ItemContextValueUnit
Revenues from external customersCurrentYTDDuration2223277000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E27585-000ResearchSupportBusinessReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E27585-000MedicalBusinessReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember－JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E27585-000ResearchSupportBusinessReportableSegmentsMember1356901000JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E27585-000MedicalBusinessReportableSegmentsMember866376000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember2223277000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember－JPY
Net salesCurrentYTDDuration2223277000JPY
Ordinary incomeCurrentYTDDuration_jpcrp040300-q3r_E27585-000ResearchSupportBusinessReportableSegmentsMember199672000JPY
Ordinary incomeCurrentYTDDuration_jpcrp040300-q3r_E27585-000MedicalBusinessReportableSegmentsMember204198000JPY
Ordinary incomeCurrentYTDDuration_ReportableSegmentsMember403870000JPY
Ordinary incomeCurrentYTDDuration_ReconcilingItemsMember-440438000JPY
Ordinary incomeCurrentYTDDuration-36567000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-02-10
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第21期第３四半期（自　2022年10月１日　至　2022年12月31日）
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社リプロセル
Company name in english cover pageFilingDateInstantReproCELL Incorporated
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　横山　周史
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)神奈川県横浜市港北区新横浜三丁目８番11号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)045-475-3887（代表）
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役CFO　赤野　滋友
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)神奈川県横浜市港北区新横浜三丁目８番11号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)045-475-3887（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役CFO　赤野　滋友
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE27585
Fund codeFilingDateInstant－
Security codeFilingDateInstant49780
Filer name in japaneseFilingDateInstant
Original text (Japanese)株式会社リプロセル
Filer name in englishFilingDateInstantReproCELL Incorporated
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstanttrue
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstantCTE
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstant－
Current fiscal year start dateFilingDateInstant2022-04-01
Current period end dateFilingDateInstant2022-12-31
Type of current periodFilingDateInstantQ3
Current fiscal year end dateFilingDateInstant2023-03-31
Previous fiscal year start dateFilingDateInstant2021-04-01
Comparative period end dateFilingDateInstant2021-12-31

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass